News

Pittsburgh, PA — Corazon, Inc., focused on program development for the Heart, Vascular, Neuroscience, Spine, Orthopedic, and Surgical specialties announced a formal partnership with the Society for Cardiovascular Angiography &...

Sophia Antipolis:  Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a heart attack or stroke, according to a study in more than 6.5 million individuals published in the European...

Around one in three women have hypertension globally. Raised blood pressure has been named the most important risk factor for death in women across the world.

The new data-driven algorithm, built on troves of electronic health records (EHR), is the first institution-specific model for assessing a cardiac patient’s risk prior to surgery.

Researchers concluded that a wider implementation of Benchmark best practices will make the TAVR pathway more efficient without compromising patient safety. 

PARIS--Elixir Medical announced that the large international randomized BIOADAPTOR RCT trial of the company’s DynamX® Coronary Drug-Eluting Bioadaptor compared to Resolute Onyx™ Drug-Eluting Stent met its primary endpoint of...

Hechingen, Germany, May 2023 – Bentley, a global leader in the endovascular treatment for aortic and peripheral vascular disease, announces their first product launch in the United States with the BeBack crossing catheter designed for the...

The five-year results from the “ABSORB IV” trial were announced Wednesday, May 17, in a Late Breaking Clinical Trials/Hotline session at the EuroPCR meeting in Paris.

Seemingly healthy people whose blood contained antibodies associated with a condition called antiphospholipid syndrome (APS) were significantly more likely to experience a cardiovascular event such as a heart attack or stroke than those...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the largest ever...